Is Trending Stock Tyson Foods, Inc. (TSN) a Buy Now?
Source: zacks.com
Zacks assigns Tyson Foods a Rank #5 (Strong Sell) after its consensus EPS estimates fell 5.9% for the current quarter, 4.3% for the current fiscal year and 4.4% for next fiscal year over the past 30 days. Current-quarter EPS is forecast at $0.65, down 43.5% year over year; the latest reported quarter missed revenue and EPS consensus by 1.91% and 3.88%, respectively. Tyson shares nevertheless gained 16.1% over the past month, versus an 11.3% rise for its industry and a 2% decline for the S&P 500; Zacks says the stock may underperform near term, while its B valuation grade indicates a discount to peers.
Analysis
The key tension is price versus earnings trajectory: TSN has rallied more than its industry while forward EPS expectations have been cut across both the current and next fiscal years. That raises the bar for upcoming results; a merely in-line quarter may not sustain the move if guidance or estimate revisions remain weak. With sales estimates offering little near-term growth, earnings recovery likely depends more on margins—protein spreads, input costs, utilization and product mix—than on volume expansion. Those drivers should be checked in segment results rather than inferred from consensus data.
Near term (days to weeks), positioning and the recent run-up leave the stock vulnerable to a reset on another estimate cut or cautious outlook. Over 1–3 months, the catalyst is evidence that margins and revisions have bottomed. Over 6–18 months, a genuine earnings recovery could make the peer-discount valuation supportive, but that is not yet established by the supplied data.
Contrarian risk: estimate-revision ranks are backward-looking signals, and next-year EPS is still forecast to grow. If the downgrades reflect a trough rather than deterioration, fading the rally could be early. The thesis weakens if consensus stabilizes or rises and reported segment margins improve; it strengthens with further cuts, weak guidance, or worsening spreads/input costs.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.35
Ticker Sentiment
Key Decisions for Investors
- Avoid chasing TSN after its relative outperformance. For an existing position, trim toward benchmark weight rather than treating the estimate trend as an automatic outright short signal.
- Tactical idea: express a modest underweight in TSN against a diversified food/meat peer basket, sized small given the possibility of an earnings trough. Confirm comparable protein exposure and liquidity before pairing; do not assume the basket is a clean hedge.
- Reassess after the next earnings release and estimate cycle. Add back only if segment-level margins improve and forward EPS revisions stop falling; reduce further if guidance or consensus estimates are cut again.
- Watch protein spreads, feed/input costs, and plant utilization alongside management guidance. A sustained margin improvement and upward revisions falsify the bearish near-term setup; continued downgrades despite stable sales would support it.
More News
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- We're raising our price target on Cardinal Health after another stellar quarter of profits
- Costco is taking aim at its May record high — how it got here and where's it going
- Neocloud IREN says $4 billion in annualized revenue being delayed due to customer request
- Tapestry CEO on Earnings Beat, Consumer Outlook